Search
for
Sort by
Research 91–120 of 636
- Trichothiodystrophy -A Case Report-
- Side effects of common acne treatments
- Management of ‘refractory’ skin disease in patients with lupus erythematosus
- Ocular involvement caused by the accumulation of porphyrins in a patient with congenital erythropoietic porphyria
- Finasteride-Induced Pseudoporphyria
- Renal tubular dysfunction presenting as recurrent hypokalemic periodic quadriparesis in systemic lupus erythematosus
- LUPUS VASCULITIS
- HIV infection mimicking autoimmune disorder
- Fundus changes in systemic lupus erythematosus
- PRESEPTAL CELLULITIS DUE TO IMPETIGO – A CASE REPORT OF UNCOMMON PRESENTATION IN PAKISTAN
- Oral and Systemic Manifestations of Systemic Lupus Erythematosus; Exploring the Association
- Systemic lupus erythematosus presenting with bullous lesions, cutaneous vasculitis and laryngeal ulcerations-a rare association
- Lupus Nephritis with Visual Field Defect Secondary to Hypertensive Retinopathy: A Case Report
- [The treatment of epilepsies with Convulsofin].
- Adverse Cutaneous Reactions to Antipsychotics
- Hair and nail involvement in lupus erythematosus
- EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines
- Characterization of tiger tail banding and hair shaft abnormalities in trichothiodystrophy
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- CONTRACEPTION AND THE SKIN
- Dermatological Manifestations of Pegylated Interferon alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients
- Photosensitive Trichothiodystrophy with Complex Cerebral Abnormalities
- Westwood Carolina Conference on Clinical Dermatology
- Prognosis and Management of Congenital Hair Shaft Disorders with Fragility—Part I
- Cutaneous lupus erythematosus
- Adverse Cutaneous Reactions to Mood Stabilizers
- Carbamazepine-Induced Hair Loss
- Non‐infective mucocutaneous presentations of human immunodeficiency virus infection
- All Subcomponents of the Cutaneous Lupus Erythematosus Disease Area and Severity Index–Activity (CLASI-A) are Relevant to Identify and Detect Changes in Skin Activity
- Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation